ProQR Therapeutics N.V. Current Accrued Expenses And Other Current Liabilities
ProQR Therapeutics N.V. (PRQR) had Current Accrued Expenses And Other Current Liabilities of EUR 8.69 million as of 2022-12-31, per its 20-F filed 2023-03-29.
Discontinued › Notes
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities · last filed 2023-03-29
- 2022-12-31: Current Accrued Expenses And Other Current Liabilities 8.69M EUR.
- 2021-12-31: Current Accrued Expenses And Other Current Liabilities 10.76M EUR.
- 2020-12-31: Current Accrued Expenses And Other Current Liabilities 6.12M EUR.
- 2019-12-31: Current Accrued Expenses And Other Current Liabilities 8.81M EUR.
| Period end | Current Accrued Expenses And Other Current Liabilities |
|---|---|
| 2022-12-31 | 8.69M EUR 20-F · filed 2023-03-29 |
| 2021-12-31 | 10.76M EUR 20-F · filed 2023-03-29 |
| 2020-12-31 | 6.12M EUR 20-F · filed 2022-04-29 |
| 2019-12-31 | 8.81M EUR 20-F · filed 2021-03-24 |
| 2018-12-31 | 7.47M EUR 20-F · filed 2020-03-31 |
| 2017-12-31 | 4.62M EUR 20-F · filed 2019-03-28 |
| 2016-12-31 | 6.06M EUR 20-F · filed 2018-03-30 |